Your browser doesn't support javascript.
Evaluation of a combination protocol of CT-first triage and active telemedicine methods by a selected team tackling COVID-19: An experimental research study.
Miyake, Shigeta; Higurashi, Takuma; Kato, Hideaki; Yamaoka, Yutaro; Kessoku, Takaomi; Kato, Shingo; Ogawa, Fumihiro; Oi, Yasufumi; Nakajima, Atsushi; Yamamoto, Tetsuya; Takeuchi, Ichiro; Ryo, Akihide; Maeda, Shin.
  • Miyake S; Team COVID-19, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Department of Neurosurgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan.
  • Higurashi T; Team COVID-19, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan. Electronic address: takuma_h@yokohama-cu.ac.jp.
  • Kato H; Team COVID-19, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Infection Prevention and Control Department, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Japan.
  • Yamaoka Y; Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan; Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Kanagawa 259-1146, Japan.
  • Kessoku T; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Palliative Care Medicine Department, Yokohama City University Hospital, 3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
  • Kato S; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Department of Clinical Cancer Genomics, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
  • Ogawa F; Team COVID-19, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan.
  • Oi Y; Team COVID-19, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan.
  • Nakajima A; Team COVID-19, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan.
  • Yamamoto T; Team COVID-19, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Department of Neurosurgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan.
  • Takeuchi I; Team COVID-19, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan.
  • Ryo A; Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan.
  • Maeda S; Team COVID-19, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan; Department of Gastroenterology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama 2360004, Japan.
J Infect Public Health ; 14(9): 1212-1217, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1364265
ABSTRACT

BACKGROUND:

Many health care workers around the world tackled with COVID-19, however sadly, the infection of many medical care workers were reported. To reduce the risk of infection, we launched selected team (Team COVID) of non-specialists and brought in active telemedicine method and computed tomography (CT)-first protocol. We describe our actual practice and the health status of medical doctors dealing with COVID-19 patients.

METHODS:

Between April 17, 2020 and May 24, 2020, 10 doctors worked with COVID-19 patients as part of Team COVID. The Team COVID doctors used a CT-first triage protocol for outpatients and telemedicine for inpatients and outpatients. We evaluated paired serum-specific antibodies for SARS-CoV-2 at the initial and end of the study duration and PCR results for SARS-CoV-2 at the end of the study duration. Furthermore, 36-item short-form of the Medical Outcome Study Questionnaire (SF-36) at the beginning and end of the study period were evaluated.

RESULTS:

Ten doctors worked as Team COVID seven internal medicine doctors and three surgeons. During the study period, Team COVID treated 165 individuals in the outpatient clinic and isolated hospitalized patients for 315 person-days. There were no positive results of serum-specific antibody testing and PCR testing for SARS-CoV-2 in Team COVID doctors. Furthermore, the SF-36 showed no deterioration in physical and mental QOL status. No in-hospital infection occurred during the study period.

CONCLUSIONS:

The Team COVID fulfilled the treatment using the active telemedicine and CT-first triage protocol without in hospital infection and excess stress. The combination strategy seems acceptable for both the protection and stress relief among the medical staff.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: Telemedicine / COVID-19 Subject: Telemedicine / COVID-19 Type of study: Patient-preference Language: English Journal: J Infect Public Health Clinical aspect: Etiology Year: 2021

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: Telemedicine / COVID-19 Subject: Telemedicine / COVID-19 Type of study: Patient-preference Language: English Journal: J Infect Public Health Clinical aspect: Etiology Year: 2021
...